The Editors of The Journal of Pediatrics encourage submissions relating to the scientific and health policy implications of the current COVID-19 pandemic that are specific to infants, children, and adolescents. The Journal of Pediatrics publishes original work promoting the latest developments in pediatric medicine, child health, policy, and advocacy. Examples of such submissions include but are not limited to
- Implications of widespread school closures
- The role of child care, including best practices in child care centers in the midst of the pandemic and hospital-based child care for employees
- Economic and clinical implications of delayed well-child and routine specialty visits
- Vaccine development and widespread implementation
- Ways in which pediatric personnel and facilities can responsibly help in a surge capacity
- Impact on trainees
Following submission, the journal will adhere to its usual desk review process for each manuscript. If a manuscript related to COVID-19 is chosen for peer review, the journal will implement a “rapid review” process in which the dedicated group of journal editors will aim to solicit and receive reviews within one week. Upon acceptance, the accepted manuscript will be posted on the journal website. Responsible sharing guidelines can be found here.
Authors have a choice in the access model and journal in which an accepted article is published. Authors can select to have their accepted article published in The Journal of Pediatrics (traditional subscription model) or The Journal of Pediatrics: X, a fully gold open access journal. Both journals share the same aims and scope, editorial team, submission system, rigorous peer review, and quality standards.
Please review our guide for authors before submitting a manuscript. Manuscripts should be submitted via the Elsevier Editorial System (EES), the electronic submission website (https://ees.elsevier.com/jpeds/). Additional information can be found through Elsevier’s Author Resources. Questions can be directed to the editorial office at [email protected].
For further support, visit Elsevier’s COVID-19 community resilience resources center.